Upstream Bio (UPB) EPS (Basic) (2023 - 2026)

Upstream Bio's EPS (Basic) history runs 4 years deep, the most recent figure standing at -$1.14 for Q1 2026.

• In Q1 2026, EPS (Basic) fell 123.59% year-over-year to -$1.14; the TTM figure through Mar 2026 stood at -$3.28 (down 95.88% YoY), while the FY2025 annual figure was -$2.66, up 52.29% from the prior year.
• EPS (Basic) for Q1 2026 stood at -$1.14, down from -$0.79 in the prior quarter.
• The five-year high for EPS (Basic) was -$0.51 in Q1 2025, with the low at -$6.96 in Q3 2024.
• The 4-year median for EPS (Basic) is -$1.59 (2024), against an average of -$2.79.
• The sharpest annual moves came in 2024 and 2025: EPS (Basic) plunged 229.2% in 2024, then jumped 91.01% in 2025.
• Upstream Bio's EPS (Basic) stood at -$5.07 in 2023, then surged by 68.61% to -$1.59 in 2024, then soared by 50.49% to -$0.79 in 2025, then sank by 44.23% to -$1.14 in 2026.
• Business Quant data shows UPB's EPS (Basic) at -$1.14 in Q1 2026, -$0.79 in Q4 2025, and -$0.63 in Q3 2025.